Hennion & Walsh Asset Management »

Taysha Gene Therapies shares owned by Hennion & Walsh Asset Management

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Hennion & Walsh Asset Management from 13F filings

Historical chart of Hennion & Walsh Asset Management investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Hennion & Walsh Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Hennion & Walsh Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.7M 309k 5.50

More positions owned by Hennion & Walsh Asset Management

Ishares Tr Core S&p500 Etf (IVV)
Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)
Goldman Sachs Etf Tr Activebeta Int (GSIE)
Wisdomtree Tr Dynamic Intl Eqt (DDWM)
Proshares Tr S&p 500 High Inc (ISPY)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Investment Grade (IGEB)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Alphabet Cap Stk Cl A (GOOGL)
NVIDIA Corporation (NVDA)
Columbia Etf Tr Ii Em Core Ex Etf (XCEM)
Broadcom (AVGO)
Ishares Tr Pfd And Incm Sec (PFF)
Amazon (AMZN)
Ishares Tr Us Sml Cap Eqt (SMLF)

View all positions for Hennion & Walsh Asset Management

Top funds holding Taysha Gene Therapies

Rtw Investments
RA Capital Management
venBio Select Advisor
BlackRock
FMR
Goldman Sachs Group
Vanguard Group
Siren
Octagon Capital Advisors
Point72 Asset Management
State Street Corporation
Vestal Point Capital
Deerfield Management Company
Polar Capital Holdings
Geode Capital Management

View all funds holding Taysha Gene Therapies